Report Summary
Premix Insulin is a combination of two insulins mixed together: one insulin that is short-acting or fast-acting, plus one insulin that is intermediate-acting. Premix Insulin can reduce postprandial blood glucose and reduce fasting blood glucose. According to the variety, premixed insulin can be divided into two categories: premixed human insulin and premixed insulin analogues.
In 2020, the global Premix Insulin market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Premix Insulin status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Premix Insulin development in United States, Europe and China.
The key players covered in this study
Novo Nordisk
Eli Lilly
Teva
Pfizer
Sanofi
...
Market segment by Type, the product can be split into
Premixed Human Insulin
Premixed Insulin Analogues
Market segment by Application, split into
Home Use
Medical Institutions
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Premix Insulin status, future forecast, growth opportunity, key market and key players.
To present the Premix Insulin development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Premix Insulin are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Premix Insulin Market Size Growth Rate by Type (2017-2027)
1.4.2 Premixed Human Insulin
1.4.3 Premixed Insulin Analogues
1.5 Market by Application
1.5.1 Global Premix Insulin Market Share by Application (2017-2027)
1.5.2 Home Use
1.5.3 Medical Institutions
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Premix Insulin Market Size
2.2 Premix Insulin Growth Trends by Regions
2.2.1 Premix Insulin Market Size by Regions (2017-2027)
2.2.2 Premix Insulin Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Premix Insulin Market Size by Manufacturers
3.1.1 Global Premix Insulin Revenue by Manufacturers (2017-2020)
3.1.2 Global Premix Insulin Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Premix Insulin Market Concentration Ratio (CR5 and HHI)
3.2 Premix Insulin Key Players Head office and Area Served
3.3 Key Players Premix Insulin Product/Solution/Service
3.4 Date of Enter into Premix Insulin Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Premix Insulin Market Size by Type (2017-2020)
4.2 Global Premix Insulin Market Size by Application (2017-2020)
5 United States
5.1 United States Premix Insulin Market Size (2017-2020)
5.2 Premix Insulin Key Players in United States
5.3 United States Premix Insulin Market Size by Type
5.4 United States Premix Insulin Market Size by Application
6 Europe
6.1 Europe Premix Insulin Market Size (2017-2020)
6.2 Premix Insulin Key Players in Europe
6.3 Europe Premix Insulin Market Size by Type
6.4 Europe Premix Insulin Market Size by Application
7 China
7.1 China Premix Insulin Market Size (2017-2020)
7.2 Premix Insulin Key Players in China
7.3 China Premix Insulin Market Size by Type
7.4 China Premix Insulin Market Size by Application
8 Japan
8.1 Japan Premix Insulin Market Size (2017-2020)
8.2 Premix Insulin Key Players in Japan
8.3 Japan Premix Insulin Market Size by Type
8.4 Japan Premix Insulin Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Premix Insulin Market Size (2017-2020)
9.2 Premix Insulin Key Players in Southeast Asia
9.3 Southeast Asia Premix Insulin Market Size by Type
9.4 Southeast Asia Premix Insulin Market Size by Application
10 India
10.1 India Premix Insulin Market Size (2017-2020)
10.2 Premix Insulin Key Players in India
10.3 India Premix Insulin Market Size by Type
10.4 India Premix Insulin Market Size by Application
11 Central & South America
11.1 Central & South America Premix Insulin Market Size (2017-2020)
11.2 Premix Insulin Key Players in Central & South America
11.3 Central & South America Premix Insulin Market Size by Type
11.4 Central & South America Premix Insulin Market Size by Application
12 International Players Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Company Details
12.1.2 Company Description and Business Overview
12.1.3 Premix Insulin Introduction
12.1.4 Novo Nordisk Revenue in Premix Insulin Business (2017-2020)
12.1.5 Novo Nordisk Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Premix Insulin Introduction
12.2.4 Eli Lilly Revenue in Premix Insulin Business (2017-2020)
12.2.5 Eli Lilly Recent Development
12.3 Teva
12.3.1 Teva Company Details
12.3.2 Company Description and Business Overview
12.3.3 Premix Insulin Introduction
12.3.4 Teva Revenue in Premix Insulin Business (2017-2020)
12.3.5 Teva Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Premix Insulin Introduction
12.4.4 Pfizer Revenue in Premix Insulin Business (2017-2020)
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Premix Insulin Introduction
12.5.4 Sanofi Revenue in Premix Insulin Business (2017-2020)
12.5.5 Sanofi Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
